QUINOXALINE COMPOUND
    3.
    发明申请
    QUINOXALINE COMPOUND 有权
    喹啉化合物

    公开(公告)号:US20110319385A1

    公开(公告)日:2011-12-29

    申请号:US13254368

    申请日:2010-03-04

    摘要: [Problem]Provided is a compound which has a PDE9-inhibiting action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like.[Means for Solution]The present inventors have investigated a compound which has a PDE9-inhibiting action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like, and thus, have found that an imidazoquinoxaline compound or a triazoloquinoxaline compound has a PDE9-inhibiting action, thereby completing the present invention. The imidazoquinoxaline compound or the triazoloquinoxaline compound of the present invention has a PDE9-inhibiting action and can be used as an agent for preventing and/or treating storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like.

    摘要翻译: [问题]提供具有PDE9抑制作用并可用作治疗和/或预防储存功能障碍,排尿功能障碍和膀胱/尿道疾病的药剂的活性成分的化合物等。 [解决方案]本发明人已经研究了具有PDE9抑制作用并可用作治疗和/或预防储存功能障碍,排尿功能障碍和膀胱/尿道疾病等的活性成分的化合物 ,因此已经发现咪唑并喹喔啉化合物或三唑并喹喔啉化合物具有抑制PDE9的作用,从而完成了本发明。 本发明的咪唑并喹喔啉化合物或三唑并喹喔啉化合物具有PDE9抑制作用,可用作预防和/或治疗储存功能障碍,排尿功能障碍和膀胱/尿道疾病等的药剂。